

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | cytidine metabolic process (GO:0046087) | 8.02197070 |
| 2 | cytidine catabolic process (GO:0006216) | 8.02197070 |
| 3 | cytidine deamination (GO:0009972) | 8.02197070 |
| 4 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 7.94773018 |
| 5 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 7.83821365 |
| 6 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 7.14605272 |
| 7 | DNA deamination (GO:0045006) | 6.31705943 |
| 8 | negative T cell selection (GO:0043383) | 6.18421595 |
| 9 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 6.15046577 |
| 10 | T cell migration (GO:0072678) | 5.87216731 |
| 11 | positive T cell selection (GO:0043368) | 5.69540883 |
| 12 | positive thymic T cell selection (GO:0045059) | 5.50330401 |
| 13 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.40252824 |
| 14 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 5.34998978 |
| 15 | actin nucleation (GO:0045010) | 5.30251341 |
| 16 | negative thymic T cell selection (GO:0045060) | 5.16030503 |
| 17 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.11876049 |
| 18 | cellular response to interleukin-15 (GO:0071350) | 5.11316311 |
| 19 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.94860632 |
| 20 | negative regulation of cell killing (GO:0031342) | 4.94860632 |
| 21 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.91213798 |
| 22 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 4.88573853 |
| 23 | thymic T cell selection (GO:0045061) | 4.81418304 |
| 24 | regulation of T cell tolerance induction (GO:0002664) | 4.80344604 |
| 25 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.68937364 |
| 26 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 4.62758789 |
| 27 | positive regulation of B cell differentiation (GO:0045579) | 4.62527484 |
| 28 | T cell selection (GO:0045058) | 4.52106974 |
| 29 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.48921948 |
| 30 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.43541653 |
| 31 | positive regulation of tolerance induction (GO:0002645) | 4.42814876 |
| 32 | response to interleukin-15 (GO:0070672) | 4.39604305 |
| 33 | regulation of activation of Janus kinase activity (GO:0010533) | 4.31999594 |
| 34 | negative regulation of viral genome replication (GO:0045071) | 4.26009901 |
| 35 | regulation of regulatory T cell differentiation (GO:0045589) | 4.25134282 |
| 36 | regulation of tolerance induction (GO:0002643) | 4.24683279 |
| 37 | cytolysis (GO:0019835) | 4.19987119 |
| 38 | regulation of gamma-delta T cell activation (GO:0046643) | 4.13596618 |
| 39 | respiratory burst (GO:0045730) | 4.07995539 |
| 40 | negative regulation of stress fiber assembly (GO:0051497) | 4.07551643 |
| 41 | regulation of T cell mediated cytotoxicity (GO:0001914) | 4.05742689 |
| 42 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 4.03492320 |
| 43 | immunoglobulin mediated immune response (GO:0016064) | 4.01308869 |
| 44 | regulation of natural killer cell mediated immunity (GO:0002715) | 3.98326943 |
| 45 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 3.98326943 |
| 46 | regulation of B cell differentiation (GO:0045577) | 3.95286926 |
| 47 | negative regulation of T cell apoptotic process (GO:0070233) | 3.94732370 |
| 48 | leukocyte aggregation (GO:0070486) | 3.94309945 |
| 49 | positive regulation of interleukin-4 production (GO:0032753) | 3.92351411 |
| 50 | T cell receptor signaling pathway (GO:0050852) | 3.90773829 |
| 51 | regulation of alpha-beta T cell proliferation (GO:0046640) | 3.82211254 |
| 52 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.78926836 |
| 53 | type I interferon signaling pathway (GO:0060337) | 3.76198466 |
| 54 | cellular response to type I interferon (GO:0071357) | 3.76198466 |
| 55 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 3.75091144 |
| 56 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.72926204 |
| 57 | T cell costimulation (GO:0031295) | 3.72643376 |
| 58 | sequestering of actin monomers (GO:0042989) | 3.72181773 |
| 59 | pyrimidine nucleoside catabolic process (GO:0046135) | 3.71569676 |
| 60 | response to pheromone (GO:0019236) | 3.71427846 |
| 61 | response to type I interferon (GO:0034340) | 3.68645402 |
| 62 | lymphocyte costimulation (GO:0031294) | 3.67458211 |
| 63 | positive regulation of cell killing (GO:0031343) | 3.64811962 |
| 64 | positive regulation of monocyte chemotaxis (GO:0090026) | 3.56651387 |
| 65 | cellular defense response (GO:0006968) | 3.56009588 |
| 66 | antigen receptor-mediated signaling pathway (GO:0050851) | 3.52871147 |
| 67 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.48386287 |
| 68 | lymphocyte migration (GO:0072676) | 3.46740885 |
| 69 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.45172094 |
| 70 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 3.45103871 |
| 71 | regulation of cell killing (GO:0031341) | 3.41417044 |
| 72 | lymphocyte chemotaxis (GO:0048247) | 3.40820680 |
| 73 | positive regulation of T cell mediated immunity (GO:0002711) | 3.36614101 |
| 74 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.32080237 |
| 75 | negative regulation of phagocytosis (GO:0050765) | 3.31203144 |
| 76 | regulation of interleukin-4 production (GO:0032673) | 3.31061075 |
| 77 | regulation of defense response to virus by virus (GO:0050690) | 3.23654679 |
| 78 | B cell mediated immunity (GO:0019724) | 3.19876806 |
| 79 | response to interferon-beta (GO:0035456) | 3.19488834 |
| 80 | dendritic cell chemotaxis (GO:0002407) | 3.19314613 |
| 81 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.11661749 |
| 82 | negative regulation of calcium ion transport into cytosol (GO:0010523) | 3.10972264 |
| 83 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 3.09355564 |
| 84 | regulation of T cell chemotaxis (GO:0010819) | 3.08636718 |
| 85 | positive regulation of T cell chemotaxis (GO:0010820) | 3.08636718 |
| 86 | B cell receptor signaling pathway (GO:0050853) | 3.02269136 |
| 87 | glucosamine-containing compound catabolic process (GO:1901072) | 3.01979749 |
| 88 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.01231709 |
| 89 | positive regulation of lamellipodium assembly (GO:0010592) | 3.00941058 |
| 90 | regulation of viral genome replication (GO:0045069) | 3.00048560 |
| 91 | cell wall macromolecule metabolic process (GO:0044036) | 2.98008543 |
| 92 | positive regulation of chemokine secretion (GO:0090197) | 2.97154563 |
| 93 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.96556620 |
| 94 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.95750871 |
| 95 | neutrophil activation (GO:0042119) | 2.94745568 |
| 96 | negative regulation of lymphocyte apoptotic process (GO:0070229) | 2.92337051 |
| 97 | chemokine-mediated signaling pathway (GO:0070098) | 2.91307299 |
| 98 | negative regulation of actin filament bundle assembly (GO:0032232) | 2.89027703 |
| 99 | regulation of T cell mediated immunity (GO:0002709) | 2.88939027 |
| 100 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.86687673 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 6.21099268 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.18510831 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.91897319 |
| 4 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.04860726 |
| 5 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 3.79336595 |
| 6 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.44785296 |
| 7 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 3.34370676 |
| 8 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.32336173 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.32180810 |
| 10 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 3.10722769 |
| 11 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.85598095 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.76462642 |
| 13 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.74914779 |
| 14 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.71567350 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.67168764 |
| 16 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.57396158 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.56733371 |
| 18 | MYB_26560356_Chip-Seq_TH1_Human | 2.52603667 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.43205811 |
| 20 | MAF_26560356_Chip-Seq_TH2_Human | 2.40617816 |
| 21 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.34239600 |
| 22 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.29717054 |
| 23 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.21314251 |
| 24 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.97264342 |
| 25 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.89453684 |
| 26 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.89344247 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.84287163 |
| 28 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83146547 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.82444853 |
| 30 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.75859699 |
| 31 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75653398 |
| 32 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.74108665 |
| 33 | GATA3_26560356_Chip-Seq_TH2_Human | 1.67791742 |
| 34 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.65962446 |
| 35 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.58226846 |
| 36 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.56735191 |
| 37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.54331429 |
| 38 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.53091994 |
| 39 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.52990390 |
| 40 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.52342215 |
| 41 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.51436104 |
| 42 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 1.50724184 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.50278344 |
| 44 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.48645039 |
| 45 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.45443491 |
| 46 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 1.45073870 |
| 47 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.42574613 |
| 48 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.38140023 |
| 49 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37171464 |
| 50 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.34611295 |
| 51 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.29270144 |
| 52 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.28476617 |
| 53 | MYC_22102868_ChIP-Seq_BL_Human | 1.26968249 |
| 54 | P68_20966046_ChIP-Seq_HELA_Human | 1.24594009 |
| 55 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23444552 |
| 56 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.17881806 |
| 57 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.17405658 |
| 58 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.14516889 |
| 59 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.13091807 |
| 60 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.11266442 |
| 61 | P300_27268052_Chip-Seq_Bcells_Human | 1.08845748 |
| 62 | SA1_27219007_Chip-Seq_Bcells_Human | 1.08335458 |
| 63 | SPI1_20517297_ChIP-Seq_HL60_Human | 1.08034511 |
| 64 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.06330808 |
| 65 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.05107495 |
| 66 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.03469684 |
| 67 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.03306262 |
| 68 | CTCF_20526341_ChIP-Seq_ESCs_Human | 1.02329005 |
| 69 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.01803126 |
| 70 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.01364257 |
| 71 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.00005749 |
| 72 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.99766705 |
| 73 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.99276322 |
| 74 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.99198750 |
| 75 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97177660 |
| 76 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.97081581 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96003349 |
| 78 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.94299748 |
| 79 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.93931908 |
| 80 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.92933009 |
| 81 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91403582 |
| 82 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 0.91129370 |
| 83 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.90443003 |
| 84 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.90399656 |
| 85 | ETS1_21867929_ChIP-Seq_TH2_Mouse | 0.89613399 |
| 86 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.88935167 |
| 87 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88710028 |
| 88 | ERA_21632823_ChIP-Seq_H3396_Human | 0.87943257 |
| 89 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.87300806 |
| 90 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.86671104 |
| 91 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 0.86632136 |
| 92 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.85824650 |
| 93 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.83773847 |
| 94 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83027929 |
| 95 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.82898428 |
| 96 | VDR_23849224_ChIP-Seq_CD4+_Human | 0.81184649 |
| 97 | SPI1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.79727437 |
| 98 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.79690521 |
| 99 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.79497925 |
| 100 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78984056 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.23841895 |
| 2 | MP0001835_abnormal_antigen_presentation | 4.09663796 |
| 3 | MP0009785_altered_susceptibility_to | 3.78731187 |
| 4 | MP0003763_abnormal_thymus_physiology | 3.35330018 |
| 5 | MP0003436_decreased_susceptibility_to | 3.15294843 |
| 6 | MP0005025_abnormal_response_to | 3.12432787 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.08816209 |
| 8 | MP0001800_abnormal_humoral_immune | 2.94517336 |
| 9 | MP0009333_abnormal_splenocyte_physiolog | 2.88360421 |
| 10 | MP0002420_abnormal_adaptive_immunity | 2.85348878 |
| 11 | MP0001819_abnormal_immune_cell | 2.77976135 |
| 12 | MP0002723_abnormal_immune_serum | 2.75988929 |
| 13 | MP0002166_altered_tumor_susceptibility | 2.72961320 |
| 14 | MP0006082_CNS_inflammation | 2.70482023 |
| 15 | MP0000685_abnormal_immune_system | 2.51414190 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.44772439 |
| 17 | MP0002419_abnormal_innate_immunity | 2.42824557 |
| 18 | MP0005387_immune_system_phenotype | 2.36379865 |
| 19 | MP0001790_abnormal_immune_system | 2.36379865 |
| 20 | MP0003866_abnormal_defecation | 2.33344667 |
| 21 | MP0002148_abnormal_hypersensitivity_rea | 2.26016868 |
| 22 | MP0003724_increased_susceptibility_to | 2.25425836 |
| 23 | MP0000716_abnormal_immune_system | 2.17822526 |
| 24 | MP0002398_abnormal_bone_marrow | 2.16767154 |
| 25 | MP0002405_respiratory_system_inflammati | 2.06811805 |
| 26 | MP0010155_abnormal_intestine_physiology | 1.95253720 |
| 27 | MP0002006_tumorigenesis | 1.92439962 |
| 28 | MP0000703_abnormal_thymus_morphology | 1.92142640 |
| 29 | MP0001873_stomach_inflammation | 1.84681912 |
| 30 | MP0001845_abnormal_inflammatory_respons | 1.84041865 |
| 31 | MP0003878_abnormal_ear_physiology | 1.82051040 |
| 32 | MP0005377_hearing/vestibular/ear_phenot | 1.82051040 |
| 33 | MP0003448_altered_tumor_morphology | 1.78953342 |
| 34 | MP0002722_abnormal_immune_system | 1.78393354 |
| 35 | MP0005410_abnormal_fertilization | 1.73474568 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.67016228 |
| 37 | MP0002429_abnormal_blood_cell | 1.65411507 |
| 38 | MP0008469_abnormal_protein_level | 1.54156863 |
| 39 | MP0000858_altered_metastatic_potential | 1.49808462 |
| 40 | MP0005464_abnormal_platelet_physiology | 1.46675595 |
| 41 | MP0002877_abnormal_melanocyte_morpholog | 1.42544886 |
| 42 | MP0004947_skin_inflammation | 1.40865131 |
| 43 | MP0001533_abnormal_skeleton_physiology | 1.33327008 |
| 44 | MP0005310_abnormal_salivary_gland | 1.30767628 |
| 45 | MP0002132_abnormal_respiratory_system | 1.28600858 |
| 46 | MP0008260_abnormal_autophagy | 1.27465949 |
| 47 | MP0002933_joint_inflammation | 1.24300877 |
| 48 | MP0001853_heart_inflammation | 1.22866021 |
| 49 | MP0003045_fibrosis | 1.20444716 |
| 50 | MP0005166_decreased_susceptibility_to | 1.19708742 |
| 51 | MP0009763_increased_sensitivity_to | 1.17165760 |
| 52 | MP0003183_abnormal_peptide_metabolism | 1.13076226 |
| 53 | MP0000604_amyloidosis | 1.09523883 |
| 54 | MP0003806_abnormal_nucleotide_metabolis | 1.07405770 |
| 55 | MP0009764_decreased_sensitivity_to | 1.03415864 |
| 56 | MP0003300_gastrointestinal_ulcer | 1.01570442 |
| 57 | MP0008961_abnormal_basal_metabolism | 0.98350804 |
| 58 | MP0004381_abnormal_hair_follicle | 0.98042034 |
| 59 | MP0003075_altered_response_to | 0.95521971 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 0.94034837 |
| 61 | MP0002693_abnormal_pancreas_physiology | 0.93611186 |
| 62 | MP0001485_abnormal_pinna_reflex | 0.92417477 |
| 63 | MP0002277_abnormal_respiratory_mucosa | 0.91723098 |
| 64 | MP0003303_peritoneal_inflammation | 0.90150259 |
| 65 | MP0002638_abnormal_pupillary_reflex | 0.82320835 |
| 66 | MP0005075_abnormal_melanosome_morpholog | 0.81599016 |
| 67 | MP0003646_muscle_fatigue | 0.78442403 |
| 68 | MP0008995_early_reproductive_senescence | 0.75634163 |
| 69 | MP0003786_premature_aging | 0.73842158 |
| 70 | MP0003191_abnormal_cellular_cholesterol | 0.70922636 |
| 71 | MP0002019_abnormal_tumor_incidence | 0.69361786 |
| 72 | MP0002998_abnormal_bone_remodeling | 0.68002359 |
| 73 | MP0002653_abnormal_ependyma_morphology | 0.67677445 |
| 74 | MP0001765_abnormal_ion_homeostasis | 0.67277620 |
| 75 | MP0003137_abnormal_impulse_conducting | 0.67031273 |
| 76 | MP0000678_abnormal_parathyroid_gland | 0.66804579 |
| 77 | MP0003172_abnormal_lysosome_physiology | 0.63595722 |
| 78 | MP0000681_abnormal_thyroid_gland | 0.62716856 |
| 79 | MP0005451_abnormal_body_composition | 0.61881506 |
| 80 | MP0000372_irregular_coat_pigmentation | 0.61727704 |
| 81 | MP0000920_abnormal_myelination | 0.58338200 |
| 82 | MP0002009_preneoplasia | 0.55225830 |
| 83 | MP0005623_abnormal_meninges_morphology | 0.54825527 |
| 84 | MP0004145_abnormal_muscle_electrophysio | 0.53753119 |
| 85 | MP0000639_abnormal_adrenal_gland | 0.52909861 |
| 86 | MP0001542_abnormal_bone_strength | 0.51982801 |
| 87 | MP0002095_abnormal_skin_pigmentation | 0.51743167 |
| 88 | MP0008873_increased_physiological_sensi | 0.51615441 |
| 89 | MP0000490_abnormal_crypts_of | 0.51339041 |
| 90 | MP0001919_abnormal_reproductive_system | 0.51117809 |
| 91 | MP0001986_abnormal_taste_sensitivity | 0.51016109 |
| 92 | MP0003795_abnormal_bone_structure | 0.50612722 |
| 93 | MP0009765_abnormal_xenobiotic_induced | 0.50432750 |
| 94 | MP0005390_skeleton_phenotype | 0.49589899 |
| 95 | MP0005379_endocrine/exocrine_gland_phen | 0.49219564 |
| 96 | MP0002163_abnormal_gland_morphology | 0.48592489 |
| 97 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.47992745 |
| 98 | MP0004510_myositis | 0.47211030 |
| 99 | MP0005636_abnormal_mineral_homeostasis | 0.45621928 |
| 100 | MP0002136_abnormal_kidney_physiology | 0.45384365 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 6.40165569 |
| 2 | Aplastic anemia (HP:0001915) | 6.04337912 |
| 3 | Abnormality of T cell number (HP:0011839) | 5.63168419 |
| 4 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.56104531 |
| 5 | Abnormality of macrophages (HP:0004311) | 4.71358577 |
| 6 | Abnormality of T cells (HP:0002843) | 4.38829074 |
| 7 | Hypoproteinemia (HP:0003075) | 4.24331380 |
| 8 | Chronic diarrhea (HP:0002028) | 4.21064157 |
| 9 | Myositis (HP:0100614) | 4.09508249 |
| 10 | Eczematoid dermatitis (HP:0000976) | 4.02884177 |
| 11 | Optic neuritis (HP:0100653) | 4.01503395 |
| 12 | Retrobulbar optic neuritis (HP:0100654) | 4.01503395 |
| 13 | Encephalitis (HP:0002383) | 3.84067405 |
| 14 | Severe combined immunodeficiency (HP:0004430) | 3.81729118 |
| 15 | IgG deficiency (HP:0004315) | 3.80567710 |
| 16 | Orchitis (HP:0100796) | 3.76276925 |
| 17 | Meningitis (HP:0001287) | 3.70748813 |
| 18 | Increased IgM level (HP:0003496) | 3.55903427 |
| 19 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.52172856 |
| 20 | Recurrent cutaneous fungal infections (HP:0011370) | 3.52172856 |
| 21 | Recurrent fungal infections (HP:0002841) | 3.50660925 |
| 22 | Lymphopenia (HP:0001888) | 3.49429471 |
| 23 | Recurrent viral infections (HP:0004429) | 3.46898753 |
| 24 | Recurrent abscess formation (HP:0002722) | 3.44483473 |
| 25 | Gastrointestinal infarctions (HP:0005244) | 3.28116320 |
| 26 | Chronic obstructive pulmonary disease (HP:0006510) | 3.25867608 |
| 27 | Obstructive lung disease (HP:0006536) | 3.25867608 |
| 28 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.24344524 |
| 29 | Stomatitis (HP:0010280) | 3.17956881 |
| 30 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.15826917 |
| 31 | Keratoconjunctivitis (HP:0001096) | 3.14573514 |
| 32 | Recurrent bacterial skin infections (HP:0005406) | 3.12916609 |
| 33 | Keratoconjunctivitis sicca (HP:0001097) | 3.11784698 |
| 34 | Combined immunodeficiency (HP:0005387) | 3.11511581 |
| 35 | Autoimmune hemolytic anemia (HP:0001890) | 3.08579067 |
| 36 | Pigmentary retinal degeneration (HP:0001146) | 2.97827386 |
| 37 | Pulmonary infiltrates (HP:0002113) | 2.97171392 |
| 38 | Mediastinal lymphadenopathy (HP:0100721) | 2.91685467 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.88769133 |
| 40 | Vasculitis (HP:0002633) | 2.86194151 |
| 41 | Recurrent skin infections (HP:0001581) | 2.85689025 |
| 42 | Nasal polyposis (HP:0100582) | 2.83122611 |
| 43 | Hemiplegia (HP:0002301) | 2.71746424 |
| 44 | Leukocytosis (HP:0001974) | 2.70409602 |
| 45 | Chest pain (HP:0100749) | 2.68103164 |
| 46 | Abnormality of T cell physiology (HP:0011840) | 2.64191418 |
| 47 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.61576518 |
| 48 | Recurrent otitis media (HP:0000403) | 2.61309820 |
| 49 | Acute hepatic failure (HP:0006554) | 2.61300523 |
| 50 | Panhypogammaglobulinemia (HP:0003139) | 2.58655111 |
| 51 | Abnormal albumin level (HP:0012116) | 2.58454980 |
| 52 | Hypoalbuminemia (HP:0003073) | 2.58454980 |
| 53 | Abnormality of the pleura (HP:0002103) | 2.56979204 |
| 54 | Severe visual impairment (HP:0001141) | 2.56596070 |
| 55 | Gangrene (HP:0100758) | 2.55355282 |
| 56 | Hypergammaglobulinemia (HP:0010702) | 2.54613264 |
| 57 | Abnormality of eosinophils (HP:0001879) | 2.53249924 |
| 58 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 2.52358952 |
| 59 | Petechiae (HP:0000967) | 2.50913204 |
| 60 | Pustule (HP:0200039) | 2.50570247 |
| 61 | Hemoptysis (HP:0002105) | 2.40324297 |
| 62 | Pulmonary embolism (HP:0002204) | 2.39395185 |
| 63 | Abnormality of the prostate (HP:0008775) | 2.38224812 |
| 64 | Increased IgE level (HP:0003212) | 2.35964514 |
| 65 | Abnormality of B cell number (HP:0010975) | 2.33591387 |
| 66 | Bronchiectasis (HP:0002110) | 2.32786987 |
| 67 | Joint swelling (HP:0001386) | 2.31129442 |
| 68 | Abnormality of the nasal mucosa (HP:0000433) | 2.30396931 |
| 69 | Lymphoma (HP:0002665) | 2.29718086 |
| 70 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.27302932 |
| 71 | B lymphocytopenia (HP:0010976) | 2.26487394 |
| 72 | Granulocytopenia (HP:0001913) | 2.25251814 |
| 73 | Purpura (HP:0000979) | 2.24019360 |
| 74 | Hypoplasia of the thymus (HP:0000778) | 2.23415324 |
| 75 | Inflammation of the large intestine (HP:0002037) | 2.23022902 |
| 76 | Autoimmune thrombocytopenia (HP:0001973) | 2.22866421 |
| 77 | Eosinophilia (HP:0001880) | 2.21736134 |
| 78 | Bronchitis (HP:0012387) | 2.21465995 |
| 79 | Attenuation of retinal blood vessels (HP:0007843) | 2.18743068 |
| 80 | IgM deficiency (HP:0002850) | 2.17584573 |
| 81 | Recurrent sinusitis (HP:0011108) | 2.14981600 |
| 82 | Gastrointestinal inflammation (HP:0004386) | 2.14538402 |
| 83 | Thyroiditis (HP:0100646) | 2.14032095 |
| 84 | Amyotrophic lateral sclerosis (HP:0007354) | 2.09695720 |
| 85 | Increased intramyocellular lipid droplets (HP:0012240) | 2.04079227 |
| 86 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.02316312 |
| 87 | Slow saccadic eye movements (HP:0000514) | 1.94680020 |
| 88 | Pancytopenia (HP:0001876) | 1.94457637 |
| 89 | Increased CSF protein (HP:0002922) | 1.93372719 |
| 90 | Agammaglobulinemia (HP:0004432) | 1.93061448 |
| 91 | Tetany (HP:0001281) | 1.90601690 |
| 92 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.88520338 |
| 93 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.88520338 |
| 94 | Anorexia (HP:0002039) | 1.87572852 |
| 95 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.83798500 |
| 96 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.83798500 |
| 97 | Abnormality of glycolipid metabolism (HP:0010969) | 1.83798500 |
| 98 | Glomerulopathy (HP:0100820) | 1.83508405 |
| 99 | Arterial thrombosis (HP:0004420) | 1.81597174 |
| 100 | Neonatal respiratory distress (HP:0002643) | 1.81016030 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | KDR | 5.31375518 |
| 2 | TXK | 5.26113448 |
| 3 | TESK2 | 4.66797181 |
| 4 | MAP4K1 | 4.48892204 |
| 5 | BCKDK | 4.01911015 |
| 6 | TESK1 | 3.11394935 |
| 7 | ITK | 2.57803944 |
| 8 | SCYL2 | 2.31783988 |
| 9 | RIPK4 | 2.30804167 |
| 10 | CSK | 2.14629449 |
| 11 | GRK6 | 2.09365622 |
| 12 | BLK | 1.84573843 |
| 13 | ZAP70 | 1.79466106 |
| 14 | FES | 1.77828122 |
| 15 | LIMK1 | 1.77076391 |
| 16 | MAP3K11 | 1.73771461 |
| 17 | SYK | 1.71568142 |
| 18 | BTK | 1.69971993 |
| 19 | CSF1R | 1.59028306 |
| 20 | MAP3K12 | 1.56188166 |
| 21 | LCK | 1.52467768 |
| 22 | EPHB1 | 1.51612231 |
| 23 | TAOK3 | 1.48383725 |
| 24 | IRAK4 | 1.41508731 |
| 25 | JAK3 | 1.37305261 |
| 26 | STK16 | 1.35271687 |
| 27 | GRK7 | 1.33325339 |
| 28 | LYN | 1.23654827 |
| 29 | TBK1 | 1.23590490 |
| 30 | IKBKE | 1.23261704 |
| 31 | MAP3K3 | 1.20994177 |
| 32 | CDK19 | 1.18326543 |
| 33 | TYK2 | 1.12412739 |
| 34 | TAOK2 | 1.11739608 |
| 35 | MAP2K6 | 1.11255792 |
| 36 | MAPKAPK3 | 1.09059132 |
| 37 | PRKCQ | 1.04243894 |
| 38 | PIK3CG | 1.01559845 |
| 39 | PASK | 0.98654300 |
| 40 | STK10 | 0.98288102 |
| 41 | HCK | 0.96950108 |
| 42 | MAP2K3 | 0.96583545 |
| 43 | CLK1 | 0.96451824 |
| 44 | TNK2 | 0.94857631 |
| 45 | TAOK1 | 0.88782720 |
| 46 | PDK1 | 0.85952459 |
| 47 | JAK2 | 0.82856177 |
| 48 | FYN | 0.76811150 |
| 49 | WNK4 | 0.70859776 |
| 50 | MAPK11 | 0.70286129 |
| 51 | ERN1 | 0.70023548 |
| 52 | ADRBK2 | 0.69009261 |
| 53 | TEC | 0.68250381 |
| 54 | PRPF4B | 0.68222419 |
| 55 | IKBKB | 0.63994444 |
| 56 | CAMKK1 | 0.59985747 |
| 57 | CAMKK2 | 0.57989919 |
| 58 | DAPK1 | 0.51276331 |
| 59 | MAP3K1 | 0.50761333 |
| 60 | JAK1 | 0.49688766 |
| 61 | MOS | 0.49074484 |
| 62 | KIT | 0.46037571 |
| 63 | FGR | 0.45652629 |
| 64 | DYRK1B | 0.42894744 |
| 65 | MAPKAPK2 | 0.41971148 |
| 66 | CDK4 | 0.39048913 |
| 67 | BMPR2 | 0.37780947 |
| 68 | MARK3 | 0.36751817 |
| 69 | INSR | 0.36119325 |
| 70 | EPHA3 | 0.31630585 |
| 71 | PIM1 | 0.31117961 |
| 72 | FGFR4 | 0.29640489 |
| 73 | ROCK1 | 0.29367650 |
| 74 | PAK1 | 0.28111476 |
| 75 | INSRR | 0.27920870 |
| 76 | LMTK2 | 0.27345804 |
| 77 | MAPK15 | 0.27092317 |
| 78 | TGFBR2 | 0.27001745 |
| 79 | IGF1R | 0.26201221 |
| 80 | ADRBK1 | 0.25463659 |
| 81 | MAP3K5 | 0.25238729 |
| 82 | IRAK1 | 0.25071716 |
| 83 | DDR2 | 0.24848368 |
| 84 | MAP4K2 | 0.24564903 |
| 85 | PDPK1 | 0.22815591 |
| 86 | PRKCH | 0.22799171 |
| 87 | EGFR | 0.21782875 |
| 88 | NEK9 | 0.21432447 |
| 89 | PTK6 | 0.20781359 |
| 90 | NEK6 | 0.20173548 |
| 91 | CSNK1G3 | 0.20094229 |
| 92 | ERBB3 | 0.17714153 |
| 93 | SIK3 | 0.17347008 |
| 94 | HIPK2 | 0.16759736 |
| 95 | MATK | 0.16664585 |
| 96 | MYLK | 0.15434833 |
| 97 | RPS6KA5 | 0.15282891 |
| 98 | SRC | 0.14913072 |
| 99 | LRRK2 | 0.14809896 |
| 100 | GRK1 | 0.14799546 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.68648985 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 4.22687834 |
| 3 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 4.18516758 |
| 4 | Allograft rejection_Homo sapiens_hsa05330 | 4.11316434 |
| 5 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.99941706 |
| 6 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.24604743 |
| 7 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 3.23709676 |
| 8 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.97028464 |
| 9 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.76101661 |
| 10 | Viral myocarditis_Homo sapiens_hsa05416 | 2.63481087 |
| 11 | Proteasome_Homo sapiens_hsa03050 | 2.10558583 |
| 12 | Measles_Homo sapiens_hsa05162 | 2.03164794 |
| 13 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.86125765 |
| 14 | Leishmaniasis_Homo sapiens_hsa05140 | 1.79262884 |
| 15 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.77761555 |
| 16 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.75706476 |
| 17 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.74799235 |
| 18 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.71302450 |
| 19 | Shigellosis_Homo sapiens_hsa05131 | 1.67996578 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.60848933 |
| 21 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.57389954 |
| 22 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.50344859 |
| 23 | Asthma_Homo sapiens_hsa05310 | 1.49845305 |
| 24 | Malaria_Homo sapiens_hsa05144 | 1.44144166 |
| 25 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.39867638 |
| 26 | Salmonella infection_Homo sapiens_hsa05132 | 1.38437784 |
| 27 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.35982310 |
| 28 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.32784546 |
| 29 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.22708842 |
| 30 | Legionellosis_Homo sapiens_hsa05134 | 1.18162704 |
| 31 | Influenza A_Homo sapiens_hsa05164 | 1.16797154 |
| 32 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.14993164 |
| 33 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.13509765 |
| 34 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.07038685 |
| 35 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.06853673 |
| 36 | Tuberculosis_Homo sapiens_hsa05152 | 1.05764070 |
| 37 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.96877019 |
| 38 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.95064088 |
| 39 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.92771200 |
| 40 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.86770025 |
| 41 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.82622990 |
| 42 | Phagosome_Homo sapiens_hsa04145 | 0.79398250 |
| 43 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.78507771 |
| 44 | Pertussis_Homo sapiens_hsa05133 | 0.77871430 |
| 45 | Endocytosis_Homo sapiens_hsa04144 | 0.77370407 |
| 46 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.77212256 |
| 47 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.77094196 |
| 48 | Phototransduction_Homo sapiens_hsa04744 | 0.76884559 |
| 49 | Parkinsons disease_Homo sapiens_hsa05012 | 0.69761940 |
| 50 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.68241923 |
| 51 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.67405570 |
| 52 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.66905206 |
| 53 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.65987019 |
| 54 | Apoptosis_Homo sapiens_hsa04210 | 0.64130768 |
| 55 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.61848808 |
| 56 | RNA polymerase_Homo sapiens_hsa03020 | 0.56889813 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.54683035 |
| 58 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.53371579 |
| 59 | HTLV-I infection_Homo sapiens_hsa05166 | 0.52606315 |
| 60 | Alzheimers disease_Homo sapiens_hsa05010 | 0.49617504 |
| 61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.48680733 |
| 62 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.44035708 |
| 63 | Prion diseases_Homo sapiens_hsa05020 | 0.43352048 |
| 64 | Huntingtons disease_Homo sapiens_hsa05016 | 0.41853823 |
| 65 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.39048623 |
| 66 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.37945453 |
| 67 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.37031001 |
| 68 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.36396814 |
| 69 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.35671054 |
| 70 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35489136 |
| 71 | Olfactory transduction_Homo sapiens_hsa04740 | 0.33377201 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 0.31466125 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.31116390 |
| 74 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.29781087 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.29699363 |
| 76 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.29508320 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.28155505 |
| 78 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.26737837 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.26421151 |
| 80 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.22990276 |
| 81 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.22141364 |
| 82 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.20266774 |
| 83 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.17916256 |
| 84 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.16239998 |
| 85 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.13324956 |
| 86 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.12853877 |
| 87 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.12813758 |
| 88 | Purine metabolism_Homo sapiens_hsa00230 | 0.12495132 |
| 89 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.12466695 |
| 90 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.09709790 |
| 91 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.06716219 |
| 92 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.06691787 |
| 93 | Peroxisome_Homo sapiens_hsa04146 | 0.05897831 |
| 94 | ABC transporters_Homo sapiens_hsa02010 | 0.05295972 |
| 95 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.05287039 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.04993927 |
| 97 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.03832452 |
| 98 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.03195158 |
| 99 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.01708245 |
| 100 | Protein export_Homo sapiens_hsa03060 | -0.0131926 |

